Robert S Sosnowski

US Patent:

6583152, Jun 24, 2003

Filed:

Apr 30, 2001

Appl. No.:

09/845141

Inventors:

Robert E. Sosnowski - Manasquan NJ
Philip C. Lang - Toms River NJ

Assignee:

DexGen Pharmaceuticals, Inc. - Manasquan NJ

International Classification:

A61K 3144

US Classification:

514289, 514284, 514282, 514249, 514185, 4241951

Abstract:

Elevated levels of homocysteine have been implicated as an important risk factor for cardiovascular and other diseases. A composition for decreasing levels of plasma homocysteine and a method for administering the composition are provided the composition containing dextromethorphan (DM), folic acid and vitamins B and B. The composition provides a synergistic therapeutic effect so that lower amounts of the above ingredients may be employed to minimize any undesirable side effects caused by the use of high levels of a component such as DM. Preferred compositions for cardiovascular diseases further include lecithin, vitamin E, beta-carotene, procyanidins/flavonoids, trimethylglycine, garlic oil and minerals. Other compositions for treating glaucoma include bilberry, bioflavonoids and beta-carotene and for treating tardive dyskinesia include an antioxidant such as grape seed extract and pine bark extract, lecithin and oligomeric proanthocyanidins. The compositions may be administered using any suitable means such as orally or intravenous.

US Patent:

20030220225, Nov 27, 2003

Filed:

Jun 23, 2003

Appl. No.:

10/601940

Inventors:

Robert Sosnowski - Manasquan NJ, US
Philip Lang - Toms River NJ, US

International Classification:

A61K031/00

US Classification:

514/001000

Abstract:

Elevated levels of homocysteine have been implicated as an important risk factor for cardiovascular and other diseases. A composition for decreasing levels of plasma homocysteine and a method for administering the composition are provided the composition containing dextromethorphan (DM), folic acid and vitamins Band B. The composition provides a synergistic therapeutic effect so that lower amounts of the above ingredients may be employed to minimize any undesirable side effects caused by the use of high levels of a component such as DM. Preferred compositions for cardiovascular diseases further include lecithin, vitamin E, beta-carotene, procyanidins/flavonoids, trimethylglycine, garlic oil and minerals. Other compositions for treating glaucoma include bilberry, bioflavonoids and beta-carotene and for treating tardive dyskinesia include an antioxidant such as grape seed extract and pine bark extract, lecithin and oligomeric proanthocyanidins. The compositions may be administered using any suitable means such as orally or intravenous.

US Patent:

20040082500, Apr 29, 2004

Filed:

Jun 23, 2003

Appl. No.:

10/601942

Inventors:

Robert Sosnowski - Manasquan NJ, US
Philip Lang - Toms River NJ, US

International Classification:

A61K031/00

US Classification:

514/001000

Abstract:

Elevated levels of homocysteine have been implicated as an important risk factor for cardiovascular and other diseases. A composition for decreasing levels of plasma homocysteine and a method for administering the composition are provided the composition containing dextromethorphan (DM), folic acid and vitamins Band B. The composition provides a synergistic therapeutic effect so that lower amounts of the above ingredients may be employed to minimize any undesirable side effects caused by the use of high levels of a component such as DM. Preferred compositions for cardiovascular diseases further include lecithin, vitamin E, beta-carotene, procyanidins/flavonoids, trimethylglycine, garlic oil and minerals. Other compositions for treating glaucoma include bilberry, bioflavonoids and beta-carotene and for treating tardive dyskinesia include an antioxidant such as grape seed extract and pine bark extract, lecithin and oligomeric proanthocyanidins. The compositions may be administered using any suitable means such as orally or intravenous.

US Patent:

20040087479, May 6, 2004

Filed:

Jun 23, 2003

Appl. No.:

10/601941

Inventors:

Robert Sosnowski - Manasquan NJ, US
Philip Lang - Toms River NJ, US

International Classification:

A61K031/00

US Classification:

514/001000

Abstract:

Elevated levels of homocysteine have been implicated as an important risk factor for cardiovascular and other diseases. A composition for decreasing levels of plasma homocysteine and a method for administering the composition are provided, the composition containing dextromethorphan (DM), folic acid and vitamins Band B. The composition provides a synergistic therapeutic effect so that lower amounts of the above ingredients may be employed to minimize any undesirable side effects caused by the use of high levels of a component such as DM. Preferred compositions for cardiovascular diseases further include lecithin, vitamin E, betacarotene, procyanidins/flavonoids, trimethylglycine, garlic oil and minerals. Other compositions for treating glaucoma include bilberry, bioflavonoids and beta-carotene and for treating tardive dyskinesia include an antioxidant such a grape seed extract and pine bark extract, lecithin and oligomeric proanthocyanidins. The compositions may be administered using any suitable means such as orally or intravenous.

US Patent:

20200017270, Jan 16, 2020

Filed:

Jul 29, 2019

Appl. No.:

16/524560

Inventors:

- East Hanover NJ, US
Justin Burns - East Hanover NJ, US
Mark Kansburg - East Hanover NJ, US
Robert Sosnowski - East Hanover NJ, US

International Classification:

B65D 75/58

Abstract:

A package containing a food product is provided where the package is configured to facilitate opening by using the food product to initiate opening of the packages. The package includes an outer wrapper with a line of weakness that is generally aligned with or above an upper profile of the food product such that when the wrapper is pulled against the food product one or more stress concentrations is created along the line of weakness due to the profile of the food product, whether in direct or near direct contact with the line of weakness of by the food product spacing front and rear walls of the wrapper apart during opening. The stress concentrations facilitate initiation of tearing or rupturing along the line of weakness such that a portion of the package can be completely or at least partially removed to expose at least a portion of the food product.

US Patent:

20170297800, Oct 19, 2017

Filed:

Oct 7, 2015

Appl. No.:

15/517023

Inventors:

- East Hanover NJ, US
Justin BURNS - East Hanover NJ, US
Mark KANSBURG - East Hanover NJ, US
Robert SOSNOWSKI - East Hanover NJ, US

International Classification:

B65D 75/58
B65D 75/58
B65D 75/58

Abstract:

A package () containing a food product () is provided where the package is configured to facilitate opening by using the food product to initiate opening of the package. The package includes an outer wrapper () with a line of weakness () that is generally aligned with or above an upper profile of the food product such that when the wrapper is pulled against the food product one or more stress concentrations is created along the line of weakness. The stress concentrations facilitate initiation of tearing or rupturing along the line of weakness () such that a portion of the package can be completely or at least partially removed to expose at least a portion of the food product ().